Effect of omega-3 on uremic pruritus hemodialysis patients

Effect of omega-3 supplement on uremic pruritus in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171220037968N1

Enrollment

Registered

2018-04-27

Start date

2017-09-30

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients. Chronic kidney disease (CKD)

Interventions

Intervention 1: Intervention group: Omega-3 capsule (1gr) that its trade name was OmegaREX made by Daana Pharma Co. was used 2gr single dose before lunch along three weeks. Intervention 2: Control gro

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: All of hemodialysis patients with uremic pruritus that their hemodialysis were started at least since three months ago

Exclusion criteria

Exclusion criteria: Patients with skin disease Patients with liver disease Patients with malignancy Patients who were allergic to omega-3

Design outcomes

Primary

Measure	Time frame
Degree of pruritus in hemodialysis patients. Timepoint: Before and 3 weeks after studing. Method of measurement: 5D ITCH SCALE Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shokouh Shayanpour

Ahvaz University of Medical Sciences

Dr.shayanpour@yahoo.com+98 61 3292 1839

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026